A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

NCT00544882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DR-1021
DRUG: Mircette®
DRUG: Kariva®

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.